New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cellectis S.A.
CLLS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

152M

Biotechnology

Next Earning date - 04 Nov 2024

152M

Biotechnology

Next Earning date - 04 Nov 2024

2.01USD
Shape0.01 ( 0.50%)
favorite-chart

Relative Strenght

86
favorite-chart

Volume Buzz

-60%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

47%

Quote Panel

Shape
Updated October 14, 2024
1W 2.55 % 1M -12.61 % 3M -3.83 % 1Y 46.72 %

Key Metrics

Shape
  • Market Cap

    152.02M


  • Shares Outstanding

    72.09M


  • Share in Float

    69.26M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    2.01


  • Average Volume

    41428


  • Beta

    3.228


  • Range

    0.963-3.774


  • Industry

    Biotechnology


  • Website

    https://www.cellectis.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

11.67x

P/S Ratio

1.22x

P/B Ratio

0.5

Debt/Equity

-613.9%

Net Margin

$-1.2

EPS

How CLLS compares to sector?

P/E Ratio

Relative Strength

Shape

CLLS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$64M

Shape698%

2025-Revenue

$0.69

Shape-148%

2025-EPS

$64M

Shape-234%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.63
vs -0.82

Q4.22

arrow
arrow

N/A

-0.57
vs -0.55

Q1.23

arrow
arrow

N/A

NA
vs NA

Q2.23

arrow
arrow

N/A

-0.14
vs -0.42

Q3.23

arrow
arrow

N/A

-0.31
vs -0.63

Q4.23

arrow
arrow

N/A

NA
vs -0.57

Q1.24

arrow
arrow

N/A

-0.57
vs NA

Q2.24

arrow
arrow

N/A

-0.28
vs -0.14

Q3.24

arrow
arrow

N/A

-0.20
vs -0.31

Q4.24

arrow
arrow

N/A

-0.15
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-97%

217K  vs 8.3M

Q4.22

arrow
arrow

+17%

16M  vs 13.6M

Q1.23

arrow
arrow

-92%

139K  vs 1.7M

Q2.23

arrow
arrow

-87%

178K  vs 1.3M

Q3.23

arrow
arrow

-29%

155K  vs 217K

Q4.23

arrow
arrow

-98%

283K  vs 16M

Q1.24

arrow
arrow

+3158%

4.5M  vs 139K

Q2.24

arrow
arrow

+4429%

8.1M  vs 178K

Q3.24

arrow
arrow

+6204%

9.8M  vs 155K

Q4.24

arrow
arrow

+5771%

16.6M  vs 283K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-18%

-0.18
vs -0.11

Q4.22

arrow
arrow

-22%

-0.22
vs -0.18

Q1.23

arrow
arrow

-26%

-0.26
vs -0.22

Q2.23

arrow
arrow

-11%

-0.11
vs -0.26

Q3.23

arrow
arrow

-23%

-0.23
vs -0.11

Q4.23

arrow
arrow

-51%

-0.51
vs -0.23

Q1.24

arrow
arrow

+6%

0.06
vs -0.51

Q2.24

arrow
arrow

-17%

-0.17
vs 0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

44

44
vs 41

7%

Q4.22

arrow
arrow

40

40
vs 44

-9%

Q1.23

arrow
arrow

30

30
vs 40

-25%

Q2.23

arrow
arrow

34

34
vs 30

13%

Q3.23

arrow
arrow

31

31
vs 34

-9%

Q4.23

arrow
arrow

35

35
vs 31

13%

Q1.24

arrow
arrow

32

32
vs 35

-9%

Q2.24

arrow
arrow

30

30
vs 32

-6%

Earnings Growth

Latest News